Safety Study of the Combination of Panitumumab, Irinotecan and Everolimus in the Treatment of Advanced Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Irinotecan
Related studies linked through entity extraction aliases.
A Study of Avastin (Bevacizumab) in Combination Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
- Status
- COMPLETED
- Phase
- PHASE2
Study of Selumetinib (AZD6244)(ARRY-142886) in Combination With Irinotecan in Previously Treated Patients With Colorec
- Status
- COMPLETED
- Phase
- PHASE2
Irinotecan and Bevacizumab for Recurrent Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
ARQ 197 in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
TACE With Irinotecan Drug-eluting Beads and Intravenous (IV) Cetuximab in Refractory Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Combination of Brivanib With 5-Fluorouracil/Leucovorin (5FU/LV) and 5-Fluorouracil/Leucovorin/Irinotecan (FOLFIRI)
- Status
- COMPLETED
- Phase
- PHASE1
Panitumumab and Irinotecan for Malignant Gliomas
- Status
- TERMINATED
- Phase
- PHASE2
OSI-906 and Irinotecan in Patients With Advanced Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors
- Status
- TERMINATED
- Phase
- PHASE3
EMD 525797 in Combination With Cetuximab and Irinotecan in K-ras Wild Type Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Vincristine, Escalating Doses of Irinotecan, Temozolomide and Bevacizumab (Vit-b) in Pediatric and Adolescent Patients With Recurrent or Refractory Solid Tumors of Non-hematopoietic Origin
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Document Long-Term Safety and Continued Benefit of Irinotecan and Carboplatin or Irinotecan in Subjects With Refractory Solid Tumors (Rollover Study -001, -002)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Surgery With Implantable Biodegradable Carmustine (BCNU) Wafer Followed by Chemo for Patients With Recurrent Glioblastoma Multiforme
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver
- Status
- COMPLETED
- Phase
- PHASE1
Avastin/Temozolomide/Irinotecan for Unresectable/Multifocal Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
CS-1008 Used With Irinotecan Versus Irinotecan Alone in Subjects With Metastatic Colorectal Carcinoma Who Failed First-line Treatment With Oxaliplatin
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)
- Status
- TERMINATED
- Phase
- PHASE1